Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Mira Pharmaceuticals Inc
MIRA
Healthcare
Biotechnology
MIRA Pharmaceuticals, Inc. is a clinical-stage pharmaceutical development company. The Company has two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. It holds exclusive license rights in the United States, Canada and Mexico for Ketamir-2 and MIRA-55, two novel drug candidates designed to address unmet medical needs in pain management, depression, PTSD and...
cognitive function. Ketamir-2 is a patent-pending oral ketamine analog evaluated for the treatment of diabetic neuropathy and is in an ongoing Phase I clinical trial. It is for patients suffering from neuropathic pain, treatment-resistant depression (TRD), major depressive disorder with suicidal ideation (MDD-SI), and post-traumatic stress disorder (PTSD). MIRA-55 is a preclinical-stage investigational drug designed to support cognitive function and enhance memory. It is for the treatment of patients experiencing cognitive decline, including those with early neurodegenerative conditions.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:MIRA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(0)
•••
PressRelease
X
Post by
PressRelease
on Sep 18, 2024 7:04am
New Press Release - MIRA Pharmaceuticals Advances Ketamir-2 Development Following Phase 1 Design Completion, Focusing on Early Clinical Efficacy Demonstration for Neuropathic Pain in 2025
MIAMI, FL / ACCESSWIRE / September 18, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company focused on developing innovative therapies for neurologic and neuropsychiatric disorders, today announced significant progress in the clinical development planning...
read article.
(38)
•••
BryceCanada
X
Post by
BryceCanada
on Sep 17, 2024 6:01pm
Great coverage on MIRA
https://youtu.be/H70KxEvFtUc?si=VQzilwNUJM3OH3u8
(0)
•••
PressRelease
X
Post by
PressRelease
on Sep 11, 2024 7:31am
New Press Release - MIRA Pharmaceuticals Designates Neuropathic Pain as Primary Indication for Ketamir-2 and Submits Pre-IND Meeting Request to FDA
MIAMI, FL / ACCESSWIRE / September 11, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company focused on developing innovative therapies for neurologic and neuropsychiatric disorders, announced today that it has selected neuropathic pain as the initial and...
read article.
(103)
•••
Iseneschal
X
Comment by
Iseneschal
on Aug 27, 2024 10:55am
RE:MIRA....held up fairly well ....all considering
$1.91 low this a.m
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Aug 26, 2024 1:05pm
MIRA....held up fairly well ....all considering
Now $2.12 Whens the P.O announcement?????
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Aug 26, 2024 9:58am
MIRA.....P.O set up
All the Chasers are going to have their heads handed back to them in a hand-basket Currently trading at $2.21...with a hogh of $2.70 Stops save portfolios ; )
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Aug 26, 2024 8:58am
MIRA...up in early a.m trading with NR
MIRA Pharmaceuticals Achieves 100% Reversal of Neuropathic Pain With Oral Ketamir-2 in Breakthrough Study 2024-08-26 05:02 ET - News Release Study Highlights Superior
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 19, 2024 7:32am
New Press Release - MIRA Pharmaceuticals Showcases Significant Progress and Announces Final Phase of Regulatory Work as It Prepares for IND Submission by Year-End
MIAMI, FL / ACCESSWIRE / August 19, 2024 / MIRA Pharmaceuticals Inc. (NASDAQ:MIRA) "MIRA" or the "Company"), a leading pre-clinical-stage pharmaceutical company, is pleased to provide a comprehensive update on its recent achievements and scientific advancements as it nears a crucial milestone...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 12, 2024 8:03am
New Press Release - MIRA Pharmaceuticals Unveils Ketamir-2's Principal Metabolite: Nor-Ketamir - a Longer-Acting, Brain Penetrating and Selective Compound Acting on the NMDA PCP Receptor
This breakthrough in bioavailability and formulation showcases the potential for advanced, at home neurological treatments.MIAMI, FL / ACCESSWIRE / August 12, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), or MIRA Pharmaceuticals, a leading pre-clinical-stage pharmaceutical company unveiled new...
read article.
(59)
•••
Nibinator
X
Post by
Nibinator
on Jul 25, 2024 10:15am
BUY BUY BUY BUY BUY
Will hit 4.5 $TODAY
(0)
•••
PressRelease
X
Post by
PressRelease
on Jul 25, 2024 7:01am
New Press Release - MIRA Pharmaceuticals Announces Positive Discovery of Ketamir-2's Selective NMDA Binding Mechanism of Action
Latest positive preclinical data provides another step in the path to potential IND submission this year for novel ketamine analogMIAMI, FL / ACCESSWIRE / July 25, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a leading pre-clinical-stage pharmaceutical company, today...
read article.
(103)
•••
Iseneschal
X
Comment by
Iseneschal
on Jul 22, 2024 4:03pm
RE:MIRA ....Halt #30? Yes today
Is that a gap down enough? Now in AH
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 22, 2024 3:49pm
MIRA..resumed & re-halt
Making it tough to sell....just sayin Me ...no position
(103)
•••
Iseneschal
X
Comment by
Iseneschal
on Jul 22, 2024 3:47pm
RE:MIRA ....Halt #30? Yes today
Been halted for over 10 mins now
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 22, 2024 3:45pm
MIRA ....Halt #30? Yes today
Halted at $5 bid & Ask......... Might be time for a gap down? Volume & price action was just perfect Who know s where this could go
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
This company is set to benefit from a change in Ontario legislation
How Web3 Will Fundamentally Reshape Finance
Largest integrated facility services provider in Canada releases financial results for Q1, 2025